Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1838585Generated: November 2, 2026

Triphenylphosphine → 4-(4-Chloro-2-fluoroanilino)6-methoxy-7-(2-(3-oxomorpholino)ethoxy)quinazoline hydrochloride

https://huagongshe.com/reaction/1838585

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriphenylphosphineHCID 11776—
Reactantethyl N-ethoxycarbonyliminocarbamateHCID 220568—
Reactant4-(2-Hydroxyethyl)morpholin-3-oneHCID 15287400—
Reactant4-(4-Chloro-2-fluorophenylamino)-7-hydroxy-6-methoxyquinazolineHCID 135513720—
SolventDichloromethaneHCID 6344—
SolventTetrahydrofuranHCID 8028—
Product4-(4-Chloro-2-fluoroanilino)6-methoxy-7-(2-(3-oxomorpholino)ethoxy)quinazoline hydrochlorideHCID 1875347779.6%

Reaction Steps

Diethyl azodicarboxylate (400 mg, 2.3 mmol) was added dropwise to a mixture of 4-(4-chloro-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline (250 mg, 0.78 mmol), (prepared as described for the starting material in Example 2), triphenylphosphine (615 mg, 2.3 mmol) and 4-(2-hydroxyethyl)-3-morpholinone (170 mg, 1.17 mmol), (EP 580402A2), in methylene chloride (5 ml) under nitrogen. The mixture was stirred for 4 hours at ambient temperature, methylene chloride (5 ml) was added and stirring was continued for a further 18 hours at ambient temperature. THF (5 ml), 4-(2-hydroxyethyl)-3-morpholinone (113 mg, 0.78 mmol), triphenylphosphine (204 mg, 0.78 mmol) were added and diethyl azodicarboxylate (136 mg, 0.78 mmol) was then added dropwise. The mixture was stirred for 5 minutes at ambient temperature, and was purified by pouring directly onto a silica column, eluting with methylene chloride/ethyl acetate/methanol (5/4/1). The purified solid was dissolved in methylene chloride and 2M methanolic hydrogen chloride (0.5 ml) was added. The mixture was concentrated by evaporation and then diluted with ether. The resulting precipitate was collected by filtration, washed with ether and dried under vacuum to give 4-(4-chloro-2-fluoroanilino)-6-methoxy-7-(2-(3-oxomorpholino)ethoxy)quinazoline hydrochloride (150 mg, 39%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06673803B2
Source datasetuspto-grants-2004_01
ORD IDord-d2adb8acf2fe442ebc6f7aef9c5629d4
Source noteuspto-grants-2004_01